Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Erythroblastic, Acute

Clinical trial condition

Leukemia, Erythroblastic, Acute

Explore clinical trials studying Leukemia, Erythroblastic, Acute. Study availability and eligibility vary by location and protocol.

130 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Erythroblastic, Acute trial results

Completed

Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

NCT00372619

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
Locations: UAB Comprehensive Cancer Center Birmingham, Alabama, United States

Southern California Permanente Medical Group Downey, California, United States

Jonathan Jaques Children's Cancer Center at Miller Children's Hospital Long Beach, California, United States

Children's Hospital Central California Madera, California, United States

View all 79 locations

View Trial Details

Completed

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

NCT01427881

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +138 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia

NCT01385150

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations: Not specified

View Trial Details

Completed

Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia

NCT00900380

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Not specified

View Trial Details

Completed

Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia

NCT01421875

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Not specified

View Trial Details

Completed

Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy

NCT01169363

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Not specified

View Trial Details

Completed

Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia

NCT01251159

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Not specified

View Trial Details

Completed

Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT01820624

Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), +26 more
Locations: University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

NCT00528398

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Banner Good Samaritan Medical Center Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

NCT00121303

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations: North Hampshire Hospital Basingstoke, England, United Kingdom

Kent and Canterbury Hospital Canterbury, England, United Kingdom

Medway Maritime Hospital Gillingham Kent, England, United Kingdom

Maidstone Hospital Maidstone, England, United Kingdom

View Trial Details